Chestnut Hill, MA, United States of America

Lihui Xu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Lihui Xu: A Pioneer in Recombinant Human Sialidases and Antibody Development

Introduction

Lihui Xu is a prominent inventor based in Chestnut Hill, MA, recognized for her significant contributions to biotechnology and therapeutic treatments. With an impressive portfolio of five patents, Xu's work focuses on innovative solutions for cancer treatment through advanced antibody and enzyme technologies.

Latest Patents

Among Xu's notable inventions are her latest patents, which include recombinant human sialidases and sialidase fusion proteins. These innovations involve sialidase that may contain mutations compared to wild-type human sialidase, enhancing their therapeutic potential. Furthermore, her invention encompasses antibody conjugates that combine sialidases with antibodies, offering promising methods for cancer treatment. Another significant patent features monospecific and bispecific antibodies aimed at human IGF-1R and ErbB3, which act as anti-neoplastic agents. This technology represents a crucial advancement in targeted cancer therapies by inhibiting signal transduction pathways linked to these receptors.

Career Highlights

Lihui Xu has held pivotal roles in several esteemed biopharmaceutical companies, including Merrimack Pharmaceuticals, Inc. and Palleon Pharmaceuticals Inc. Her work in these organizations has contributed to the development of groundbreaking cancer therapies and therapeutic targets.

Collaborations

Throughout her career, Xu has collaborated with talented professionals, including Jason Baum and Bryan Johnson. These partnerships have facilitated innovative research and development, leading to significant breakthroughs in the field of biotechnology.

Conclusion

Lihui Xu's dedication to innovation in biomedicine highlights her as an inspiring figure in the scientific community. Her advancements in recombinant human sialidases and antibody therapies not only demonstrate her expertise but also her commitment to improving cancer treatment options. With a robust patent portfolio and a collaborative spirit, Xu continues to pave the way for future discoveries in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…